September 21, 2017 — Fujitsu announced that the University of Tokyo recently used heart simulator viewers with stereoscopic displays compatible with virtual reality (VR) technology in an electrocardiogram lecture for third year students in the Faculty of Medicine. The lecture was given by Associate Professor Toshiaki Nakajima of Dokkyo Medical University Heart Center.

Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia aortic valve, the first in a new class of resilient heart valves.

September 21, 2017 — Toshiba Medical will highlight its latest magnetic resonance imaging (MRI) technology, led by the Vantage Titan/Zen Edition and Vantage Galan 3T, at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago.

September 20, 2017 — Not-for-profit preclinical research institute CBSET announced that its scientists have published data and analyses providing critical insights into the barrier effects of calcified plaque on drug delivery and the treatment success of adjunctive lesion preparation therapy.

Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress, Sept. 16-20 in Copenhagen, Denmark.